Human Parvovirus B19 and Blood Products
- 1 January 1997
- journal article
- research article
- Published by Wiley in Vox Sanguinis
- Vol. 72 (1) , 1-10
- https://doi.org/10.1046/j.1423-0410.1997.00001.x
Abstract
Background and objectives: Human B19 parvovirus (B19), identified in 1975, was only recognised as the causative agent of fifth disease in 1983. The incidence of viraemia is low, around 1 in 1,000, b...Keywords
This publication has 119 references indexed in Scilit:
- Transfusion‐transmitted human parvovirus B19 infection in a thalassemic patientTransfusion, 1995
- Persistent parvovirus B19 infectionThe Lancet, 1995
- B19 parvovirus DNA in solvent/detergent-treated anti-haemophilia concentratesThe Lancet, 1994
- Persistent human parvovirus B19 infection following an acute infection with meningitis in an immunocompetent patientEuropean Journal of Clinical Microbiology & Infectious Diseases, 1993
- Human parvovirus B19-associatedarthritis in childrenThe Journal of Pediatrics, 1993
- Removal of parvovirus B19 from contaminated factor VIII during fractionationJournal of Medical Virology, 1991
- Human Parvovirus B19New England Journal of Medicine, 1989
- Pure Red-Cell Aplasia of 10 Years' Duration Due to Persistent Parvovirus B19 Infection and Its Cure with Immunoglobulin TherapyNew England Journal of Medicine, 1989
- Human Parvo Virus B19 Infection among Hospital Staff Members after Contact with Infected PatientsNew England Journal of Medicine, 1989
- TRANSMISSION OF SERUM PARVOVIRUS-LIKE VIRUS BY CLOTTING-FACTOR CONCENTRATESThe Lancet, 1983